{"id":"W3035473078","doi":"10.1158/1078-0432.ccr-20-1345","title":"A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Bendamustine; Rituximab; Lenalidomide; Medicine; Bortezomib; Follicular lymphoma; Internal medicine; Oncology; Lymphoma; Follicular phase; Multiple myeloma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00303779,0.001302502,0.002299833,0.000377778,0.0004136344,0.001043927,0.001280594,0.001571846,0.006208881],"category_scores_gemma":[0.00175129,0.0006668701,0.001571963,0.0003724841,0.00115941,0.0009128681,0.0004361525,0.003448217,0.001212632],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001069547,"about_ca_system_score_gemma":0.001714918,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008890121,"about_ca_topic_score_gemma":0.00247033,"domain_scores_codex":[0.9990151,0.0006139952,0.00004823016,0.0001355538,0.00006385311,0.0001232175],"domain_scores_gemma":[0.99862,0.0003007598,0.0002820512,0.0001208494,0.0000814787,0.0005949527],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9697958,0.01407498,0.0006854204,0.000165143,0.0004819127,0.00002289142,0.00003554,0.0002563501,0.003035605,0.00004862887,0.0005293475,0.0108684],"study_design_scores_gemma":[0.9107876,0.08665569,0.00150109,0.00001183121,0.0001796781,0.00001821957,0.00001093094,0.0002386471,0.0002297765,0.00006177064,0.0002967622,0.000008003491],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918131,0.00150111,0.0005622178,0.000457476,0.0002689406,0.00344347,0.0006550899,0.00008506075,0.00121359],"genre_scores_gemma":[0.9885505,0.001038428,0.001541432,0.001219544,0.0003181774,0.00403831,0.001065047,0.00002839156,0.002200178],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006208881,"threshold_uncertainty_score":0.02077073,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.25055410467249,"score_gpt":0.5022630588164514,"score_spread":0.2517089541439614,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}